Weiss Multi-Strategy Advisers’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
Other funds holding PETX
BC
WIC
AAM
GAI
OAC
Weiss Multi-Strategy Advisers's PETX Position: Q2 2019 in Review
Weiss Multi-Strategy Advisers sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 175,000 shares — an estimated $630K sold.
Weiss Multi-Strategy Advisers first reported a position in PETX in Q1 2014 and held it in 21 quarters. The position peaked at $1.36M in Q2 2015. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.
- Weiss Multi-Strategy Advisers reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 175,000 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $630K.
- Weiss Multi-Strategy Advisers first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 21 quarters.
- Weiss Multi-Strategy Advisers's Aratana Therapeutics, Inc. position peaked at $1.36M in Q2 2015.
- 103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.